Skip to search formSkip to main contentSkip to account menu

farnesylamine

National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Farnesol
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Oxidative stress-dependent inhibition of yeast cell growth by farnesylamine and its possible relation to amine oxidase in the mitochondrial fraction.
2003
2003
Farnesylamine from the ant Monomorium fieldi Forel.
(2E)- and (2Z)-Farnesylamine were detected in the extracts of the myrmicine ant Monomorium fieldi Forel from Australia. Their… 
2002
2002
[Oleylamine (long-chain fatty amine)-induced cell death through MAP kinase pathways in human pancreatic cancer cells].
We have previously shown that farnesylamine which acts as a farnesyltransferase inhibitor (FTI) induces apoptosis in human… 
2001
2001
Requirement of c-jun N-terminal kinase for apoptotic cell death induced by farnesyltransferase inhibitor, farnesylamine, in human pancreatic cancer cells.
Farnesyltransferase inhibitors (FTIs) represent a novel class of anticancer drugs and are now in clinical trial. We have… 
1998
1998
Selective cytotoxicity of farnesylamine to pancreatic carcinoma cells and Ki‐ras–transformed fibroblasts
Farnesyl protein transferase (FPTase) catalyses the post‐translational modification of proteins by a farnesyl pyrophosphate. One… 
1994
1994
Effects of long-chain fatty amines on the growth of ras-transformed NIH 3T3 cells.
1993
1993
Farnesylamine: an inhibitor of farnesylation and growth of ras-transformed cells.
Farnesylamine, an analogue of farnesol, was shown to inhibit growth of PAP2 cells (ras-transformed NIH 3T3 cells) in a dose… 
1993
1993
Famesylamine: An inhibitor of famesylation and growth ofras-transformed cells
Farnesylamine, an analogue of farnesol, was shown to inhibit growth of PAP2 cells (ras-transformed NIH 3T3 cells) in a dose… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)